Ignota Labs

AI-enabled drug rescue and development for pharmaceutical and biotech partners seeking to revive drugs stalled by safety issues

Cambridge, United KingdomFounded 2021ignotalabs.aiWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

About Ignota Labs

Ignota Labs acquires or identifies drug candidates stalled by safety problems, uses its SAFEPATH platform to investigate toxicity mechanisms, and re-engineers compounds into new drug assets. It develops assets to key milestones before selling or partnering them.

SAFEPATH applies machine learning to bioinformatics and cheminformatics data to generate and prioritize hypotheses about drug targets and toxicity. The company is based in Cambridge, UK, and was founded in 2021.

Product: Drug rescue and development services and assets, supported by the SAFEPATH AI platform for investigating drug toxicity.

Jobs at Ignota Labs

No open positions listed right now.

Leadership

  • Jordan Lane · Chief Scientific Officer and Co-Founder
  • Layla Hosseini-Gerami · Chief Data Science Officer and Co-Founder
  • Sam Windsor · Chief Executive Officer and Co-Founder
  • Kelly Gray · Chief Operating Officer

More biotech & pharma companies

  • Ilc Therapeutics

    Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSV
    Edinburgh, United KingdomBiotech & pharmaFounded 2012
  • Imaging Endpoints

    Oncology imaging CRO that designs, reads and analyses imaging endpoints for pharma sponsors' clinical trials
    Harrow, United KingdomBiotech & pharmaFounded 2021
  • Imhotex

    Develops a drug candidate for Crohn’s disease through a virtual biopharmaceutical model
    Cambridge, United KingdomBiotech & pharmaFounded 2020
    New on Evolc
  • immunesystems.co.uk

    UK supplier of antibodies, ELISA kits, labeling kits and lab reagents for life sciences researchers and producers
    United KingdomBiotech & pharma
    New on Evolc
  • Immunocore

    Develops bispecific T cell receptor immunotherapies for cancer, infectious and autoimmune diseases
    Abingdon, United KingdomBiotech & pharmaFounded 2007
  • Immunokey

    Develops CAR T-cell therapies for solid cancers, starting with ovarian cancer
    Wilmslow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Content management

  • WebflowHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

  • AWSHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • WorkableMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.